Pfizer (NYSE:PFE) will report earnings before markets open on Tuesday, April 30th. Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
Here is your Cheat Sheet to Pfizer Earnings:
Earnings Expectations: Analysts expect earnings of $0.56 per share on revenues of $14.01 billion. Currently, the company’s P/E ratio stands at 16.01.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.58 to a profit $0.6. For the current year, the average estimate is a profit of $2.28, which is worse than the estimate ninety days ago.
Here’s how Pfizer has been performing on an annual basis:
|Revenue ($) in millions||48,300||50,010||65,160||65,260||58,990|
|Diluted EPS ($)||1.20||1.23||1.02||1.27||1.94|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||16,140||15,400||15,060||13,980||15,070|
|Diluted EPS ($)||0.1868||0.24||0.43||0.43||0.8555|
Pfizer has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)